|
The Texas HIV Medication Program (THMP) provides medications for the treatment of HIV and its related complications for low-income Texans. To qualify for medications, potential clients who meet eligibility criteria complete an application for assistance. Once approved, a client receives medications at an assigned pharmacy in their community.
To learn more about the THMP and find out if you are eligible, see the
Frequently Asked Questions. You can apply for the program by downloading and completing the
client application. Be sure and review the specific “application instructions” when completing the application. The application and its instructions are located on the
THMP document page. If you have more questions or need assistance completing your application, call the THMP toll free at 1 (800) 255-1090.
The THMP is the official AIDS Drug Assistance Program (ADAP) for the State of Texas. The THMP has been in existence since 1987 and provides medications approved by the Food and Drug Administration (FDA) for the treatment of illnesses caused by the human immunodeficiency virus (HIV) and other opportunistic infections in HIV-infected individuals as prescribed by their doctor. THMP also operates the Texas HIV State Pharmaceutical Assistance Program (SPAP) which helps HIV-positive individuals that do not qualify for the full Low Income Subsidy (extra help) with their out-of-pocket costs associated with Medicare Part D prescription drug plans, including co-payments, deductibles, coinsurance, and during the coverage gap (the "donut hole").
News
Texas HIV Medication Advisory Committee Meeting Scheduled for July 19
The next Texas HIV Medication Advisory Committee meeting will be held on Friday, July 19 from 12:30 to 3:30 p.m. at:
Health and Human Services Commission
Brown Heatly Building
Public Hearing Room 1410/1420/1430
4900 North Lamar Boulevard
Austin, Texas 78751 This meeting will be webcast. To access the webcast, go to https://hhs.texas.gov/about-hhs/communications-events/live-archived-meetings the day and time of the meeting. Please e-mail Webcasting@hhsc.state.tx.us if you have any problems with the webcasting function. Agenda - Call to Order and Welcome - Philip Keiser, M.D., Committee Chair
- Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
- Review and Approval of April 5, 2019, Meeting Minutes - Sallie Allen, Advisory Committee Coordination Office, HHSC
- LIDS Update/Legislative Update – Imelda Garcia, Associate Commissioner, DSHS
- Budget Update – Felipe Rocha, MSSW Director TB/HIV/STD Section
- THMP Update – Rachel Sanor, Manager
- Presentation on Dovato – Viiv Healthcare, Medical Science Liaison
- Sub-Committee Reports (Governance/Data – Phillip Keiser, Eligibility – Frank Rosas, and Formulary – Natalie Vanek)
- MAC to vote for addition of the following medications
- Dovato
- Hepatitis B medications
- Hepatitis C medications
- MAC to vote for removal of the following medications
- Delavirdine
- Indinavir
- MAC to vote on officer elections process
- Public Comment – Sallie Allen, Advisory Committee Coordination Office, HHSC
- Action items and agenda topics for next scheduled meeting October 18, 2019 - Philip Keiser, M.D., Chair
- Adjourn - Philip Keiser, M.D., Committee Chair
Contact: Questions regarding agenda items, content, or meeting arrangements should be directed to Mary Richards, Pharmacy Coordinator, Department of State Health Services, 1 800 255-1090, or Mary.Richards@dshs.texas.gov. This meeting is open to the public. No reservations are required, and there is no cost to attend this meeting. Persons with disabilities who plan to attend this meeting and require auxiliary aids or services are asked to contact Anne Mosher, Department of State Health Services, telephone (512) 776-2780 or anne.mosher@dshs.texas.gov, at least 72 hours prior to the meeting so that appropriate arrangements may be made.
|
News
6/18/2019: Two New Medications Added to THMP Formulary
Two medications have been added to the Texas HIV Medication Program Formulary:
- Delstrigo tablets (doravirine/lamivudine/tenofovir disoproxil fumarate) (100 mg/300 mg/300mg; 30 tablets per box)
- Pifeltro tablets (doravirine) (100 mg; 30 tablets per box)
The Medical Certification Form, THMP Formulary List, Program Guidelines and Pharmacy Guidelines have all been updated to reflect the additional medication, and are all available for download on the THMP Documents page. Should you have any questions, please call the THMP at 1-800-255-1090. |
News
5/13/2019: New Medication Added to THMP Formulary
THMP has added Trogarzo to our formulary. If you (or your client) have been prescribed Trogarzo and do not have health insurance, please contact us at 1-800-255-1090. If you are eligible for or currently enrolled in THMP, THMP and DSHS Ryan White Care Services will work together to identify a participating pharmacy and a Ryan White funded infusion center to help you start treatment. |
|
|
THMP Eligibility Flyer (PDF : 782 kB)
THMP Eligibility Flyer (Spanish) (PDF : 786 kB)
THMP Email Lists
THMP Email Lists
Sign up to one or more email lists below today to receive timely and relevant news from THMP: |
THMP News
Less frequent updates with news about significant events for the THMP program.
Subscribe to THMP News |
THMP Participating Pharmacies
Updates of interest to THMP participating pharmacies.
Subscribe to THMP Participating Pharmacies |
THMP Eligibility
Information for ADAP Enrollment Workers and others who assist clients in THMP application submission and their supervisors.
Subscribe to THMP Eligibility | |